Our recent findings highlight a marked increase in medium-chain fatty acids (MCFAs) and a decrease in short-chain fatty acids (SCFAs) in ALS patients, with similar alterations observed in SOD1 mice. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.